- News & Analysis
Page 540
Lava heats up with MRL funding
Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.
Jun 1, 2018Neurent catches scent of $10.9m series A
NUI Galway's Neurent Medical has been backed by government investors WDC and Enterprise Ireland as it continues development on its rhinitis treatment device.
Jun 1, 2018MEIF helps Locate to $2.7m round
Nottingham spinout Locate Therapeutics is developing a polymer-based material that ensures stem cells and other therapies can be injected with precision.
May 31, 2018Lava heats up with MRL funding
Cancer therapy developer Lava Therapeutics has raised $18.6m in a round featuring Merck Research Laboratories unit MRL Ventures.
May 31, 2018Evotec makes it three for three
Fred Hutchinson Cancer Research Center is the third institution to gain an academic bridge program in collaboration with Evotec, with the latest instalment dubbed Lab591.
May 31, 2018AvroBio ambles to $86m IPO
The EMS-backed gene therapy developer has filed for an $86.3m offering having raised about the same amount in venture funding.
May 31, 2018Eidos Therapeutics elbows its way to $115m IPO
BridgeBio Pharma retains a majority stake in spinoff Eidos, which has raised $91m in funding in just over a year.
May 31, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin